4774-18-9

Usage

Uses

Currently, there is limited information available on the specific applications of 2-(Benzyloxy)-6-chloropyrazine. However, based on its classification as a pyrazine, it can be inferred that it may have potential uses in various industries, such as:
Used in Flavor and Fragrance Industry:
2-(Benzyloxy)-6-chloropyrazine could be used as a flavoring agent or a fragrance component for its strong odor, which might be desirable in certain applications.
Used in Pharmaceutical Industry:
As a chemical compound, 2-(Benzyloxy)-6-chloropyrazine may have potential applications in the development of pharmaceutical products, possibly as an active ingredient or as a part of a drug delivery system. Further research would be required to explore its potential in this field.
Used in Chemical Research:
2-(Benzyloxy)-6-chloropyrazine could be used as a research compound in academic or industrial settings, where its chemical properties and interactions with other compounds are studied to gain a better understanding of its potential applications and effects.

InChI:InChI=1/C11H9ClN2O/c12-10-6-13-7-11(14-10)15-8-9-4-2-1-3-5-9/h1-7H,8H2

Upstream product

• 4774-14-5 2,6-dichloropyrazine 
• 100-51-6 benzyl alcohol 

Downstream Products

• 181582-01-4 (3R,4R,5R)-3,4-Bis-benzyloxy-2-(3-benzyloxy-5-chloro-pyrazin-2-yl)-5-benzyloxymethyl-tetrahydro-furan-2-ol 
• 1313033-58-7 2-(benzyloxy)-6-ethylpyrazine 
• 1279817-20-7 2-benzyloxy-6-phenylpyrazine 
• 1644057-99-7 C₂₃H₃₆N₂OSn 
• 1644057-97-5 2-(benzyloxy)-6-(thien-2-yl)pyrazine 
• 1644057-96-4 C₁₈H₁₆N₂O₂ 
• 181581-96-4 3-Benzyloxy-2-((2S,3S,4R,5R)-3,4-bis-benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-yl)-5-chloro-pyrazine 

Relevant academic research and scientific papers

Regioselective addition of Grignard reagents to N-acylpyrazinium salts: Synthesis of substituted 1,2-dihydropyrazines and Δ5-2-oxopiperazines

The regioselective addition of Grignard reagents to mono- and disubstituted N-acylpyrazinium salts affording substituted 1,2-dihy-dropyrazines in modest to excellent yields (45–100%) is described. Under acidic conditions, these 1,2-dihydropyrazines can be converted to substituted Δ5-2-oxopiperazines providing a simple and efficient approach towards their preparation.

SYK INHIBITORS

The present disclosure a Syk compound inhibitors, including state cancer and inflammation and various disease States thereof in the treatment of relates to the use of. In one aspect a particular embodiment, . given by formula I which is marked as a chemical structure of compound. In formula said, X 1, X 2, X 3, R 2, R 3, R 4, R 5, and Y has described herein is. The present disclosure of a formula I compounds or a pharmaceutically acceptable salt of pharmaceutical compositions including, mediated by Syk and to treat conditions a employing these compounds and compositions further provides a method. (by machine translation)

Synthesis of mono- and diaza-'pyridones' via stille coupling of alkoxystannanes

Various alkoxy-substituted heterocyclic stannanes provide access to the corresponding substituted 'pyridone' moieties via Stille cross-coupling. Both pyridyl and a series of diazinyl stannanes are prepared, and options for unmasking (via demethylation or debenzylation) of the pyridone unit are evaluated. Georg Thieme Verlag Stuttgart. New York.

Selective Ligands for the Neuronal Nicotinic Receptors and Uses Thereof

The present application describes selective ligands of formula (I) for neuronal nicotinic receptors (NNRs), more specifically for the α4β2 NNR subtype, compositions thereof, and methods of using the same, wherein X, R1, X, R2, R3, L1, m, n, p, and q are defined in the specification.

Alkanesulfonate derivatives and their use as insecticides, acaricides or nematicides

Disclosed herein is a compound of the formula: wherein Ar is pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, isoquinoline ring or thiazole ring, and those rings may be substituted by 1?3 of substituents selected from the group consisting of halogen, C1 ?C4 -alkyl, C1 ?C4 -alkoxy, CF3 and nitro, R1 is C1 ?C8 -alkyl; C1 ?C7 -alkyl which is substituted by 1?3 of F, Cl or Br, C1 ?C4 -alkoxy or C1 ?C4 -alkylthio; C3 ?C7 -cycloalkyl which may be substituted by 1?4 of F, Cl or methyl; C3 ?C6 -cycloalkylmethyl which may be substituted by 1?4 of F, Cl, Br or methyl; allyl, propargyl, phenyl or benzyl; R2 is C1 ?C4 -alkyl which may be substituted by 1?3 of F or Cl, x is integer of 0, 1 or 2, excepting wherein Ar is pyridine ring which is substituted by R1 --S(O)x and --O--SO2 R2 at 2- and 6-position and the R1 is C1 ?C7 -alkyl and the pyridine ring is not further substituted or substituted by 1?3 of halogen.